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Clinical Case Report
ABSTRACT
Metastatic gallbladder carcinoma to the ovaries is occasional but a recognized entity. It can mimic, clinical and 
morphologically, a primary ovarian tumor, challenging the diagnosis. We present the case of a patient with a lump in 
the hypogastrium extending into the right iliac fossa and was found to have abdominopelvic cystic lesion with enhancing 
solid components and multiple sub-centimetric and ill-defined abdominal lymph nodes. Also, subpleural and parenchymal 
nodules in the lungs were present. She subsequently underwent a laparotomy. Cholecystectomy was also done due to 
pre-existing symptomatic biliary lithiasis. The histologic report described the ovarian involvement as metastases from a 
gallbladder carcinoma. The presentation of ovarian metastases can challenge the diagnosis. Hence, careful evaluation of 
the digestive tract and judicious use of immunohistochemistry should be considered in patients presenting with ovarian 
masses. 
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INTRODUCTION
The ovary is a frequent site of metastases from a 
wide variety of malignant neoplasms, mostly from the 
gastrointestinal tract. The gallbladder and bile ducts are 
rare sources of these metastases. Primary gallbladder 
cancer metastasizing to the ovary is infrequent and 
reported to be a meager 6%, and only a few cases 
have been reported.1 Many of these cases were initially 
misdiagnosed as a primary ovarian tumor. In these 
cases, the lack of awareness or limited information 
could cause an incorrect diagnosis.2 As gallbladder 
carcinoma also has a mucinous histology subtype, it 
becomes a diagnostic challenge to differentiate the 
primary ovarian cancer from the secondary when 
synchronous tumors are diagnosed. Furthermore, the 
similar non-specific clinical symptoms, signs, imaging 
findings, and tumor markers preclude the clinician from 
an accurate diagnosis.3 It is important to differentiate 
the two malignancies, as the management and 
prognosis are different. We report a case in which the 
patient presented with a lump abdomen. The patient 
was initially managed as a case of primary ovarian 
tumors. However, the gallbladder carcinoma identified 
incidentally during the histopathological examination 
after the exploratory laparotomy was the primary 
carcinoma, and the ovary was the metastatic focus.
CASE REPORT
A 49-year-old female presented with complaints 
of right iliac fossa pain and lump abdomen for one 
year. There was no history of weight loss, loss of 
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appetite, or early satiety. On examination, she was 
afebrile and well hydrated with stable vitals. There 
was no pallor, icterus, lymphadenopathy, or pedal 
edema. The thyroid and breast examination were 
normal. However, the abdominopelvic examination 
revealed a 10x8 cm lump in hypogastrium extending 
into the right iliac fossa with restricted mobility. The 
hematological and biochemical tests were normal. 
The serum tumor markers recorded values of: CA125 
58.63 U/ml (reference value RV <46U/ml), AFP 4 ng/ml 
(RV: 10-20 ng/ml), β-HCG 2.12 mIU/ml (RV <5mIU/ml), 
and CA-19.9 17.2 IU/μl (RV: <37IU/ml). The pelvic 
ultrasonography revealed a heterogeneous cystic lesion 
with septations and solid components in the right 
adnexal region of 13.4 x 12 x 12cm. The abdominal 
contrast-enhanced computed tomography (CT) and 
Magnetic Resonance Imaging (MRI) revealed a well-
defined abdominopelvic cystic lesion measuring 
13x12x10cm with enhancing solid components of 
ovarian origin (Figure 1), and multiple subcentimetric 
and ill-defined subpleural and pulmonary nodules in 
the right upper lobe, right middle lobe and left upper 
lobe. The patient subsequently underwent a diagnostic 
laparoscopy. The intraoperative findings revealed 
a large adnexal mass, solid and cystic with minimal 
ascites and small sub-centimetric omental nodules. 
An omental biopsy was sent for histopathological 
examination, which showed fibrofatty tissue infiltrated 
by malignant cells seen as irregular glands eliciting a 
desmoplastic stromal response. In view of the above 
findings, optimal primary cytoreduction was feasible.
Hence, she underwent staging laparotomy - Total 
abdominal hysterectomy with bilateral salpingo-
oophorectomy along with bilateral pelvic as well as 
paraaortic lymphadenectomy and omentectomy, 
appendectomy, and cholecystectomy. In addition to 
the previous findings, intra-operative findings showed 
multiple pelvic lymph nodes, ascites, and thickened 
gallbladder. A frozen section was sent intra-operative 
from the ovarian mass indicated a borderline malignant 
tumor. On gross examination, the right ovary measured 
13 x 10 x 05 cm and left ovary measured 06 x 03 x 
03 cm. Both ovaries had a solid-cystic cut surface 
(Figure 2). The gallbladder measured 05 cm in 
length with an irregularly thickened wall measuring 
1.5- 2.5 cm (Figure 2).
The maximum wall thickness was seen in the 
fundus with the puckering of the corresponding serosa. 
The mucosa was irregular.
The histopathological examination from both 
ovaries showed an infiltrative tumor arranged in 
varying sized glands, many of which were cystically 
dilated, enclosing a pale mucinous material (Figure 3B). 
These glands were lined by cuboidal to columnar cells 
having basally placed large, pleomorphic nuclei with 
open to clumped chromatin, prominent nucleoli, and 
moderate pale eosinophilic to mucin filled cytoplasm 
(Figure 3C). The sections from the gallbladder showed 
a dysplastic mucosa along with underlying infiltrative 
glands, which are lined by cuboidal to columnar cells 
having similar morphology to those seen in both 
ovaries (Figure 3A). Perineural invasion was noted, and 
the tumor was seen to infiltrate the muscle to breach 
the serosa. Immunohistochemistry showed the tumor 
cells in the ovary as well as the in the gallbladder to be 
of the same phenotype, being positive for CK7 (Clone 
OV-TL, Pathnsitu, Ready to use) (intense, cytoplasmic), 
CK19 (Clone EP-73, Pathnsitu, Ready to use) (intense, 
cytoplasmic) and CDX2 (Clone EP-25, Pathnsitu, Ready 
to use) (focal, nuclear); while being negative for WT1 
Figure 1. Magnetic resonance imaging (T1 weighted) 
shows a solid cystic ovarian mass with internal septations.
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Figure 2. A – The cut surface of the right and left ovary shows a solid-cystic lesion with areas of necrosis (Scale bar: 
3 cm); B – left ovary; C – thickened gallbladder wall.
Figure 3. A – Photomicrograph of the gallbladder shows infiltrating irregular glands eliciting a desmoplastic response 
(H&E, 40x); B, C and D – Photomicrograph of right ovarian mass B - shows cystically dilated infiltrative glands (H&E, 
40x); (C) shows the glands being lined by cuboidal to columnar cells having large vesicular nuclei, prominent nuclei 
and moderate amphophilic cytoplasm (H&E, 40x); (D) Cytokeratin 7 (40x magnification).
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(Clone EP-122, Pathnsitu, Ready to use), ER (Clone EP1, 
Pathnsitu, Ready to use), PR (Clone EP2, Pathnsitu, 
Ready to use) and CK20 (Clone EP-23, Pathnsitu, Ready 
to use) (Figure 3D, Figure 4A and 4B). P53 (Clone 
BP-53-12, Pathnsitu, Ready to use) showed mutant 
expression (50% cytoplasmic blush).
A final diagnosis of gallbladder carcinoma, Stage 
IVB (pT3NxM1) was made, considering only the para-
aortic lymph nodes. The post-operative period was 
uneventful, and she was started on a gemcitabine-
based palliative chemotherapy regimen.
DISCUSSION
Metastatic neoplasms involving the ovary are 
sources of numerous problems in the differential 
diagnosis for the pathologist and have been the subject 
of much interest.4 Diverse issues have been emphasized, 
including but not limited to the remarkable mimicry of 
primary ovarian mucinous neoplasia in some cases. The 
morphology of metastatic intestinal adenocarcinoma, 
dating in large part from the seminal observations of 
Lash and Hart;5 and the delineation of a wider spectrum 
of the morphology of the Krukenberg tumor of the 
ovary than had previously been known for the most 
part.6 Additional patterns that were nonspecific have 
also complicated the morphology. However, there 
was also the small to medium-sized glandular pattern 
characteristic of many primary tumors of the biliary 
and pancreatic region.
The frequency with which the pathologist is 
confronted with a metastatic tumor of the gallbladder 
or extrahepatic bile duct origin varies worldwide 
because of the difference in the incidence of primary 
cancer. The clinical presentation of many tumors mimics 
that of primary ovarian neoplasia. The characteristics of 
gallbladder carcinomas with metastasis to the ovary on 
imaging may be similar to cholecystitis or cholelithiasis 
without obvious signs of polypoidal mass.7 Most 
patients present with nonspecific abdominal or pelvic 
symptoms (pain, distension, or mass), and a few, 
occasionally, present with jaundice. The operative 
findings can frequently note abnormalities in and 
around the primary site that will raise the suspicion 
of nonovarian origin. The surface involvement and a 
multinodular growth pattern are common, both very 
characteristic of metastasis.6 However, in our case, 
there was no evident surface involvement, and the 
gallbladder was removed only because the patient 
had a history of chronic cholecystitis. Morphologic 
heterogeneity from area to area within an individual 
slide is also very typical of metastasis.
Metastatic mucinous tumors can be very similar 
to the primary ovarian mucinous tumors, grossly. 
Our case showed the right ovary having multiple 
mucin-filled cystic areas along with many areas of 
necrosis. The solid areas were also mostly necrosed 
with evidence of hemorrhage. Grossly, the gallbladder 
did not show any mass, but its wall was diffusely 
thickened. Occasionally, these tumors pose major 
diagnostic problems microscopically, particularly 
when there is a bland-appearing epithelium or an 
adenofibroma or cystadenoma-like pattern. The 
presence of these bland and borderline-like areas 
Figure 4. Photomicrographs of the ovary tumor. A – tumor cells positive reaction for cytokeratin 19 (40x); B – CDX2 
shows nuclear staining in tumor cells (400x). 
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could mislead one into concluding that the carcinoma 
arose out of a background primary ovarian neoplasm. 
Not infrequently, well-differentiated glands and cysts 
dispersed in prominent fibrous stroma strikingly 
mimicked ovarian adenofibroma, and similar well-
differentiated cysts in a less conspicuous stroma 
mimicked a cystadenoma.2 Similar misinterpretation of 
such an area as a pre-existing ovarian lesion could lead 
one to wrongly conclude that the entire process was 
primary in the ovary. Awareness of this phenomenon 
and attention to the clinical findings, gross features, 
and other histologic indicators of metastatic disease, 
as noted previously, should enable one to avoid this 
diagnostic pitfall. However, in a limited sample, such 
as the intraoperative frozen section, this can be a 
particularly treacherous area.
In our case, the histopathological examination 
from both ovaries showed an infiltrative tumor 
arranged in varying sized glands, many of which were 
cystically dilated, enclosing pale mucinous material 
suggestive of a mucinous cystadenocarcinoma. 
However, the surprise came when the gallbladder 
sections showed a dysplastic mucosal lining along 
with underlying infiltrative glands having similar 
morphology as that seen in both the ovaries. In lieu of 
a high index of suspicion of a gallbladder carcinoma, 
the immunohistochemistry was done to differentiate 
between the two synchronous tumors. Though 
CK7/CK20 immune profile is extensively studied 
for differentiating colorectal cancer from mucinous 
ovarian carcinoma, data on their role in gallbladder 
carcinoma are limited. Our IHC showed the tumor 
cells in the ovary as well as the gallbladder to be of 
the same phenotype, being positive for CK7 (intense, 
cytoplasmic), CK19 (intense, cytoplasmic), and CDX2 
(focal, nuclear); while being negative for WT1, ER, 
PR, and CK20. P53 showed mutant expression 
(50% cytoplasmic blush). This immune profile of 
CK7+/CK20-/CK19+/p53+ is typical of gallbladder 
carcinomas (GBC). In addition, GBCs have also known 
to express CEA, CA19-9, S100p, and MUC1.8 Primary 
mucinous ovarian tumors (PMOT) in contrast are 
usually unilateral, large, multicystic masses having a 
smooth surface, seldom showing infiltrative histology 
with nuclear expression of PAX8 and dual positivity 
for CK7 and CK20.9
The importance of differentiating primary 
gallbladder cancer from ovarian cancer is because of 
the different management. The 5-year survival rate of 
primary gallbladder cancer is abysmal (5%), whereas 
that of stage IV ovarian is 19%, and stage III ovarian 
cancer is (40-50%).3 Unlike primary ovarian cancers, 
the role of surgical management in gallbladder 
cancer is limited to early-stage disease. The use of 
either radiotherapy or chemotherapy provides little 
improvement in survival for patients with advanced 
primary gallbladder cancers. Moreover, chemotherapy 
regimens for both are different.10,11 For unresectable 
gallbladder carcinomas, the preferred regimen is 
Gemcitabine based while Platinum-based regimens 
are preferred for advanced Ovarian carcinomas.10-12
CONCLUSION
Occult gallbladder carcinoma presenting initially 
as a metastatic tumor to the ovary has not been widely 
studied. These tumors can closely mimic primary 
ovarian mucinous tumors. In spite of extensive cross-
sectional radiological imaging and serum markers, an 
accurate diagnosis may not be possible preoperatively. 
Pathologists should always maintain a high index of 
suspicion, and adequate sampling should be done 
of bilateral ovarian masses. In all bilateral mucinous 
tumors, the outer surface should be sifted through 
for the presence of tiny deposits. Knowing the extent 
to which gallbladder metastases may mimic a primary 
ovarian tumor, differentiating histological features, 
and appropriate use of immunohistochemistry will help 
make the correct diagnosis and provide direction for 
further patient management.
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